Steven Cohen's ETRA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 47,005 shares of Electra Therapeutics, Inc. (ETRA) worth $528,806, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in ETRA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Electra Therapeutics (ETRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Electra Therapeutics (ETRA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +47,005 | New Buy | 47,005 | $11.25 |
Steven Cohen's Electra Therapeutics Investment FAQs
Steven Cohen first purchased Electra Therapeutics, Inc. (ETRA) in Q3 2026, acquiring 47,005 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Electra Therapeutics, Inc. (ETRA) for 1 quarters since Q3 2026.
Steven Cohen's largest addition to Electra Therapeutics, Inc. (ETRA) was in Q3 2026, adding 47,005 shares worth $528,806.
According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 47,005 shares of Electra Therapeutics, Inc. (ETRA), valued at approximately $528,806.
As of the Q3 2026 filing, Electra Therapeutics, Inc. (ETRA) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Electra Therapeutics, Inc. (ETRA) was 47,005 shares, as reported at the end of Q3 2026.